Research ArticleCancer Drug Development

Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors

Science Translational Medicine  04 Aug 2010:
Vol. 2, Issue 43, pp. 43ra55
DOI: 10.1126/scitranslmed.3001065

Log in to view full text

As a service to the community, AAAS/Science has made this article free with registration.

Navigate This Article